Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study.
Nakai Y, Isayama H, Sasaki T, Sasahira N, Tsujino T, Toda N, Kogure H, Matsubara S, Ito Y, Togawa O, Arizumi T, Hirano K, Tada M, Omata M, Koike K. Nakai Y, et al. Among authors: ito y. Br J Cancer. 2012 Jun 5;106(12):1934-9. doi: 10.1038/bjc.2012.183. Epub 2012 May 3. Br J Cancer. 2012. PMID: 22555398 Free PMC article. Clinical Trial.
[Radiation therapy for malignant lymphoma].
Ito Y, Ishikura S, Ogino T, Ikeda H. Ito Y, et al. Nihon Rinsho. 2000 Mar;58(3):709-14. Nihon Rinsho. 2000. PMID: 10741151 Review. Japanese.
Prognostic nomogram for nonresectable pancreatic cancer treated with gemcitabine-based chemotherapy.
Hamada T, Nakai Y, Yasunaga H, Isayama H, Matsui H, Takahara N, Sasaki T, Takagi K, Watanabe T, Yagioka H, Kogure H, Arizumi T, Yamamoto N, Ito Y, Hirano K, Tsujino T, Tada M, Koike K. Hamada T, et al. Among authors: ito y. Br J Cancer. 2014 Apr 15;110(8):1943-9. doi: 10.1038/bjc.2014.131. Epub 2014 Mar 18. Br J Cancer. 2014. PMID: 24642625 Free PMC article.
Results of a multi-institutional, randomized, non-inferiority, phase III trial of accelerated fractionation versus standard fractionation in radiation therapy for T1-2N0M0 glottic cancer: Japan Clinical Oncology Group Study (JCOG0701).
Kodaira T, Kagami Y, Shibata T, Shikama N, Nishimura Y, Ishikura S, Nakamura K, Saito Y, Matsumoto Y, Teshima T, Ito Y, Akimoto T, Nakata K, Toshiyasu T, Nakagawa K, Nagata Y, Nishimura T, Uno T, Kataoka M, Yorozu A, Hiraoka M; Radiation Therapy Study Group of the Japan Clinical Oncology Group. Kodaira T, et al. Among authors: ito y. Ann Oncol. 2018 Apr 1;29(4):992-997. doi: 10.1093/annonc/mdy036. Ann Oncol. 2018. PMID: 29401241 Free article. Clinical Trial.
12,153 results
You have reached the last available page of results. Please see the User Guide for more information.